Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: A substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial

International Journal of Cardiology

Volumn 168, Issue 6, 2013, Pages 5287-5292

  Farooq, Vasim ^a   Serruys, Patrick W ^a   Vranckx, Pascal ^a,k   Bourantas, Christos V ^a   Girasis, Chrysafios ^a   Holmes, David R ^b   Kappetein, Arie Pieter ^a   Mack, Michael ^c   Feldman, Ted ^d   Morice, Marie Claude ^e   Colombo, Antonio ^f   Morel, Marie Angèle ^g   De Vries, Ton ^g   Dawkins, Keith D ^h   Mohr, Friedrich W ⁱ   James, Stefan ^j   Ståhle, Elisabeth ^j  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MAYO CLINIC   (United States)

^c MEDICAL CITY DALLAS HOSPITAL   (United States)

^d EVANSTON HOSPITAL   (United States)

^e Institut Jacques Cartier   (France)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g CARDIALYSIS   (Netherlands)

^h BOSTON SCIENTIFIC CORPORATION   (United States)

ⁱ UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^j UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^k Jessaziekenhuis Hasselt   (Belgium)

more..

Author keywords

Biomarkers; CABG; Mortality; PCI; SYNTAX

Indexed keywords

CLOPIDOGREL; CREATINE KINASE; CREATINE KINASE MB; PACLITAXEL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE;

ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY BIFURCATION LESION; DRUG ELUTING STENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYNTAX SCORE;

BIOMARKERS; CABG; MORTALITY; PCI; SYNTAX;

CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; CREATINE KINASE; CREATINE KINASE, MB FORM; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; MALE; PACLITAXEL; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBULIN MODULATORS;

EID: 84887187642     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.013     Document Type: Article

References (33)

1. P. Vranckx, V. Farooq, and S. Garg Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting Heart 98 2012 1424 1430
2. M.J. Domanski, K. Mahaffey, and V. Hasselblad Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery JAMA 305 2011 585 591
3. S.J. Brener, B.W. Lytle, J.P. Schneider, S.G. Ellis, and E.J. Topol Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality J Am Coll Cardiol 40 2002 1961 1967
4. M.A. Costa, R.G. Carere, and S.V. Lichtenstein Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the arterial revascularization therapies study (ARTS) Circulation 104 2001 2689 2693
5. M.C. Morice, P.W. Serruys, and A.P. Kappetein Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial Circulation 121 2010 2645 2653
6. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
7. A.T. Ong, P.W. Serruys, and F.W. Mohr The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase Am Heart J 151 2006 1194 1204
8. A.P. Kappetein, T.E. Feldman, and M.J. Mack Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial Eur Heart J 32 2011 2125 2134
9. SYNTAX score calculator http://www.syntaxscore.com SYNTAX Working-Group 2009 [Launched 19th May 2009]
10. P.W. Serruys, Y. Onuma, and S. Garg Assessment of the SYNTAX score in the Syntax study EuroIntervention 5 2009 50 56
11. G. Sianos, M.A. Morel, and A.P.K. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease EuroIntervention 2005 219 227
12. V. Farooq, S. Brugaletta, and P.W. Serruys Contemporary and evolving risk scoring algorithms for percutaneous coronary intervention Heart 97 2011 1902 1913
13. S.J. Head, V. Farooq, P.W. Serruys, and A.P. Kappetein The SYNTAX score and its clinical implications Heart 2013 10.1136/heartjnl-2012-302482
14. H. Tunstall-Pedoe, K. Kuulasmaa, P. Amouyel, D. Arveiler, A.M. Rajakangas, and A. Pajak Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents Circulation 90 1994 583 612
15. R.J. Little, R. D'Agostino, and M.L. Cohen The prevention and treatment of missing data in clinical trials N Engl J Med 367 2012 1355 1360
16. R.M. Califf, A.E. Abdelmeguid, and R.E. Kuntz Myonecrosis after revascularization procedures J Am Coll Cardiol 31 1998 241 251
17. V. Guru, J. Omura, A.A. Alghamdi, R. Weisel, and S.E. Fremes Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials Circulation 114 2006 I331 I338
18. W.O. Myers, E.H. Blackstone, K. Davis, E.D. Foster, and G.C. Kaiser CASS Registry long term surgical survival, Coronary Artery Surgery Study J Am Coll Cardiol 33 1999 488 498
19. R.T. van Domburg, A.P. Kappetein, and A.J. Bogers The clinical outcome after coronary bypass surgery: a 30-year follow-up study Eur Heart J 30 2009 453 458
20. T.Q. Kong, C.J. Davidson, S.N. Meyers, J.T. Tauke, M.A. Parker, and R.O. Bonow Prognostic implication of creatine kinase elevation following elective coronary artery interventions JAMA 277 1997 461 466
21. A.E. Abdelmeguid, S.G. Ellis, S.K. Sapp, P.L. Whitlow, and E.J. Topol Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions Am Heart J 131 1996 1097 1105
22. J.P. Ioannidis, E. Karvouni, and D.G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J Am Coll Cardiol 42 2003 1406 1411
23. J.S. Jang, H.Y. Jin, and J.S. Seo Prognostic value of creatine kinase-myocardial band isoenzyme elevation following percutaneous coronary intervention: a meta-analysis Catheter Cardiovasc Interv 81 6 2013 959 967
24. A. Colombo, J.W. Moses, and M.C. Morice Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions Circulation 109 2004 1244 1249
25. L. Ge, I. Iakovou, and J. Cosgrave Treatment of bifurcation lesions with two stents: one year angiographic and clinical follow up of crush versus T stenting Heart 92 2006 371 376
26. A. Latib, A. Colombo, and G.M. Sangiorgi Bifurcation stenting: current strategies and new devices Heart 95 2009 495 504
27. A. Colombo, and R. Al-Lamee Bifurcation lesions: an inside view Circ Cardiovasc Interv 3 2010 94 96
28. D. Hildick-Smith, J.F. Lassen, and R. Albiero Consensus from the 5th European Bifurcation Club meeting EuroIntervention 6 2010 34 38
29. D. Hildick-Smith, A.J. de Belder, and N. Cooter Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies Circulation 121 2010 1235 1243
30. R. Diletti, H.M. Garcia-Garcia, and C.V. Bourantas Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial Heart 99 17 2013 1267 1274
31. M.C. Dillon, D.F. Calbreath, and A.M. Dixon Diagnostic problem in acute myocardial infarction: CK-MB in the absence of abnormally elevated total creatine kinase levels Arch Intern Med 142 1982 33 38
32. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
33. V. Farooq, P.W. Serruys, and C. Bourantas Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) trial Eur Heart J 33 2012 3105 3113